Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP252915.RAEyL-yY2twOP-pm7RXvaAu3JMypOHUWCG2z3KwmF_JNM130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP252915.RAEyL-yY2twOP-pm7RXvaAu3JMypOHUWCG2z3KwmF_JNM130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP252915.RAEyL-yY2twOP-pm7RXvaAu3JMypOHUWCG2z3KwmF_JNM130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP252915.RAEyL-yY2twOP-pm7RXvaAu3JMypOHUWCG2z3KwmF_JNM130_provenance.
- NP252915.RAEyL-yY2twOP-pm7RXvaAu3JMypOHUWCG2z3KwmF_JNM130_assertion description "[ASC amino-acid transporter 2 was expressed in 66% of patients, and was closely correlated with disease stage, lymphatic permeation, vascular invasion, CD98, cell proliferation, angiogenesis, and mTOR phosphorylation, particularly in patients with adenocarcinoma (AC).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP252915.RAEyL-yY2twOP-pm7RXvaAu3JMypOHUWCG2z3KwmF_JNM130_provenance.
- NP252915.RAEyL-yY2twOP-pm7RXvaAu3JMypOHUWCG2z3KwmF_JNM130_assertion evidence source_evidence_literature NP252915.RAEyL-yY2twOP-pm7RXvaAu3JMypOHUWCG2z3KwmF_JNM130_provenance.
- NP252915.RAEyL-yY2twOP-pm7RXvaAu3JMypOHUWCG2z3KwmF_JNM130_assertion SIO_000772 24603303 NP252915.RAEyL-yY2twOP-pm7RXvaAu3JMypOHUWCG2z3KwmF_JNM130_provenance.
- NP252915.RAEyL-yY2twOP-pm7RXvaAu3JMypOHUWCG2z3KwmF_JNM130_assertion wasDerivedFrom befree-20150227 NP252915.RAEyL-yY2twOP-pm7RXvaAu3JMypOHUWCG2z3KwmF_JNM130_provenance.
- NP252915.RAEyL-yY2twOP-pm7RXvaAu3JMypOHUWCG2z3KwmF_JNM130_assertion wasGeneratedBy ECO_0000203 NP252915.RAEyL-yY2twOP-pm7RXvaAu3JMypOHUWCG2z3KwmF_JNM130_provenance.
- befree-20150227 importedOn "2015-02-27" NP252915.RAEyL-yY2twOP-pm7RXvaAu3JMypOHUWCG2z3KwmF_JNM130_provenance.